Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT05714553	TitleNUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours	Fase Phase 1, Phase 2	Date Added 2023-02-06	Ubicación Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Docetaxel, Fosifloxuridine Nafalbenamide, Leucovorin, Pembrolizumab	Etiquetas MSI-H/ MMRd
NCT ID NCT04332653	TitleNT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors	Fase Fase 1	Date Added 2020-04-03	Ubicación Florida, United States Michigan, United States Missouri, United States North Carolina, United States Pennsylvania, United States Tennessee, United States Texas, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas NT-I7, Pembrolizumab	Etiquetas MSS/ MMRp
NCT ID NCT04041310	TitleNous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors	Fase Phase 1, Phase 2	Date Added 2019-08-01	Ubicación California, United States Florida, United States Indiana, United States Maryland, United States Missouri, United States New York, United States Texas, United States Bélgica Canadá Italia España Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas	Etiquetas MSI-H/ MMRd
NCT ID NCT05213195	TitleTerapia celular NKG2D CAR-NK en pacientes con cáncer colorrectal metastásico refractario	Fase Fase 1	Date Added 2022-01-28	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas NKG2D CAR-NK	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04575922	TitleNivolumab+Ipilimumab+RT in MSS mCRC	Fase Fase 2	Date Added 2020-10-05	Ubicación Massachusetts, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Ipilimumab, Nivolumab	Etiquetas MSS/ MMRp
NCT ID NCT03104439	TitleNivolumab e Ipilimumab y radioterapia en cáncer colorrectal y de páncreas con MSS y MSI alto	Fase Fase 2	Date Added 2017-04-07	Ubicación Massachusetts, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ipilimumab, Nivolumab, Opdivo, Yervoy	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03983993	TitleNiraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2019-06-12	Ubicación Georgia, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Niraparib, panitumumab, Vectibix, Zejula	Etiquetas MSS/ MMRp
NCT ID NCT04940546	TitleNeoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in pMMR/MSS CRLM Patients	Fase Phase 1, Phase 2	Date Added 2021-06-25	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Bevacizumab, capecitabine, oxaliplatin, Sintilimab	Etiquetas MSS/ MMRp
NCT ID NCT05798533	TitleNeo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)	Fase Fase 1	Date Added 2023-04-04	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Cyclophosphamide, Fludarabine, Interleukin-2	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05783089	TitleMSLN-targeted CAR-T Cells in Solid Tumors.	Fase Fase 1	Date Added 2023-03-24	Ubicación	Prior IO Allowed Sí	CRC-directed Sí	Status Aún no se ha contratado	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 121 to 130 of 299 entries